EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of Periostin Alternative Splicing Variants in Normal Tissue and Breast Cancer

Yuko Kanemoto, Fumihiro Sanada iD, Kana Shibata, Yasuo Tsunetoshi, Naruto Katsuragi, Nobutaka Koibuchi, Tetsuhiro Yoshinami, Koichi Yamamoto, Ryuichi Morishita, Yoshiaki Taniyama iD, Kenzo Shimazu

Biomolecules · 2024

DOI: 10.3390/biom14091093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Yuko Kanemoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Suita 565-0871, Japan. Hauptthemen laut MEDLINE: Alternative Splicing, Breast Neoplasms, Cell Adhesion Molecules. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: a grant-in-aid from JSPS KAKENHI, a grant-in-aid from Japan Agency for Medical Research and Development Grant number, a grant-in-aid from G7 Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Periostin (Pn) is a secreted protein found in the extracellular matrix, and it plays a variety of roles in the human body. Physiologically, Pn has a variety of functions, including bone formation and wound healing. However, it has been implicated in the pathogenesis of various malignant tumors and chronic inflammatory diseases. Pn has alternative splicing variants (ASVs), and our previous research revealed that aberrant ASVs contribute to the pathogenesis of breast cancer and heart failure. However, the difference in expression pattern between physiologically expressed Pn-ASVs and those expressed during pathogenesis is not clear. (2) Methods and results: We examined normal and breast cancer tissues, focusing on the Pn-ASVs expression pattern to assess the significance of pathologically expressed Pn-ASVs as potential diagnostic and therapeutic targets. We found that most physiologically expressed Pn isoforms lacked exon 17 and 21. Next, we used human breast cancer and normal adjacent tissue (NAT) to investigate the expression pattern of Pn-ASVs under pathological conditions. Pn-ASVs with exon 21 were significantly increased in tumor tissues compared with NAT. In situ hybridization identified the synthesis of Pn-ASVs with exon 21 in peri-tumoral stromal cells. Additionally, the in vivo bio-distribution of 89Zr-labeled Pn antibody against exon 21 (Pn-21Ab) in mice bearing breast cancer demonstrated selective and specific accumulation in tumors, while Pn-21Ab significantly suppressed tumor growth in the mouse breast cancer model. (3)

Conclusions

Together, these data indicate that Pn-ASVs might have potential for use as diagnostic and therapeutic targets for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingBreast NeoplasmsCell Adhesion MoleculesHumansFemaleAnimalsMiceProtein IsoformsGene Expression Regulation, NeoplasticExonsPeriostin

Stichwörter der Autor:innen

alternative splicing variantsbreast cancerextracellular matrix proteinperiostin

Substanzen

POSTN protein, humanCell Adhesion MoleculesProtein IsoformsPeriostin

Autor:innen und Institutionen

  • Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
  • Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
  • Department of Advanced Molecular Therapy, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
  • Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.

ORCID-Profile: Fumihiro Sanada, Yoshiaki Taniyama

Förderung

  • a grant-in-aid from JSPS KAKENHI
  • a grant-in-aid from Japan Agency for Medical Research and Development Grant number
  • a grant-in-aid from G7 Foundation
  • the Grants in Aid for Scientific Research (C), 2024-2029
  • START Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.
  • JSPS KAKENHI
  • Japan Agency for Medical Research and Development
  • G7 Foundation

Zitieren

APA

Kanemoto, Y., Sanada, F., Shibata, K., Tsunetoshi, Y., Katsuragi, N., Koibuchi, N., Yoshinami, T., Yamamoto, K., Morishita, R., Taniyama, Y., & Shimazu, K. (2024). Expression of Periostin Alternative Splicing Variants in Normal Tissue and Breast Cancer. Biomolecules. https://doi.org/10.3390/biom14091093

Vancouver

Kanemoto Y, Sanada F, Shibata K, Tsunetoshi Y, Katsuragi N, Koibuchi N, et al. Expression of Periostin Alternative Splicing Variants in Normal Tissue and Breast Cancer. Biomolecules. 2024. doi:10.3390/biom14091093

BibTeX
@article{Kanemoto2024,
  author = {Kanemoto, Yuko and Sanada, Fumihiro and Shibata, Kana and Tsunetoshi, Yasuo and Katsuragi, Naruto and Koibuchi, Nobutaka and Yoshinami, Tetsuhiro and Yamamoto, Koichi and Morishita, Ryuichi and Taniyama, Yoshiaki and Shimazu, Kenzo},
  title = {Expression of Periostin Alternative Splicing Variants in Normal Tissue and Breast Cancer},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14091093}
}
Kostenlos starten →